U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C4H5NO4.2K
Molecular Weight 209.2834
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIPOTASSIUM ASPARTATE

SMILES

[K+].[K+].N[C@@H](CC([O-])=O)C([O-])=O

InChI

InChIKey=IKALZAKZWHFNIC-JIZZDEOASA-L
InChI=1S/C4H7NO4.2K/c5-2(4(8)9)1-3(6)7;;/h2H,1,5H2,(H,6,7)(H,8,9);;/q;2*+1/p-2/t2-;;/m0../s1

HIDE SMILES / InChI

Molecular Formula K
Molecular Weight 39.0983
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C4H5NO4
Molecular Weight 131.0868
Charge -2
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/15703381 | https://www.ncbi.nlm.nih.gov/pubmed/3814227 | https://www.ncbi.nlm.nih.gov/pubmed/16061593

Disodium aspartate is used in organic biosynthesis.

CNS Activity

Curator's Comment: Aspartic acid is produced in the brain and acts as endogenous neurotransmitter.

Originator

Curator's Comment: Aspartic acid was first discovered in 1827 by Auguste-Arthur Plisson and Étienne Ossian Henry by hydrolysis of asparagine, which had been isolated from asparagus juice in 1806

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Q7L266
Gene ID: 80150.0
Gene Symbol: ASRGL1
Target Organism: Homo sapiens (Human)
18.4 µM [EC50]
Target ID: P08236
Gene ID: 2990.0
Gene Symbol: GUSB
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Doses

Doses

DosePopulationAdverse events​
6 g 1 times / day multiple, oral
Highest studied dose
Dose: 6 g, 1 times / day
Route: oral
Route: multiple
Dose: 6 g, 1 times / day
Sources:
healthy, 22.4 ± 2.6 years
n = 10
Health Status: healthy
Age Group: 22.4 ± 2.6 years
Sex: M
Population Size: 10
Sources:
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG

OverviewOther

Other InhibitorOther SubstrateOther Inducer







Drug as perpetrator​

Drug as perpetrator​

TargetModalityActivityMetaboliteClinical evidence
no
Drug as victim
PubMed

PubMed

TitleDatePubMed
The biosynthesis of nicotinamide adenine dinucleotides in bacteria.
2001
Selective cleavage of BLM, the bloom syndrome protein, during apoptotic cell death.
2001 Apr 13
Expression pattern and gene characterization of asporin. a newly discovered member of the leucine-rich repeat protein family.
2001 Apr 13
Aging-induced changes in 24-h rhythms of mitogenic responses, lymphocyte subset populations and neurotransmitter and amino acid content in rat submaxillary lymph nodes during Freund's adjuvant arthritis.
2001 Feb
Protective effect of allopurinol on hepatic energy metabolism in ischemic and reperfused rat liver.
2001 Feb
Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology.
2001 Feb
Factors associated with the risk of liver enzyme elevation in patients with type 2 diabetes treated with a thiazolidinedione.
2001 Feb
Nicotinic receptors mediate the release of amino acid neurotransmitters in cultured cortical neurons.
2001 Feb
Comparison of clinical, virologic and pathologic features in patients with acute hepatitis B and C.
2001 Feb
Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes.
2001 Feb
Endotoxin clearance and its relation to hepatic and renal disturbances in rats with liver cirrhosis.
2001 Feb
Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS).
2001 Feb
Extracellular amino acid levels measured with intracerebral microdialysis in the model of posttraumatic epilepsy induced by intracortical iron injection.
2001 Feb
Serum hepatic biochemical activity in two populations of workers exposed to styrene.
2001 Feb
Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen.
2001 Feb
Central infusions of the recombinant human prolactin receptor antagonist, S179D-PRL, delay the onset of maternal behavior in steroid-primed, nulliparous female rats.
2001 Feb
Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant.
2001 Feb
A molecular variant of the APC gene at codon 1822: its association with diet, lifestyle, and risk of colon cancer.
2001 Feb 1
Protective effect of stiripentol on acetaminophen-induced hepatotoxicity in rat.
2001 Feb 1
Evidence for glutamate receptor mediated transmission at mechanoreceptors in the skin.
2001 Feb 12
Changes in striatal electroencephalography and neurochemistry induced by kainic acid seizures are modified by dopamine receptor antagonists.
2001 Feb 16
Evidence for microvesicular storage and release of glycine in rodent pinealocytes.
2001 Feb 16
Coagulation profile, hepatic function, and hemodynamics following Fontan-type operations.
2001 Jan
Comparison of the efficacy and tolerability of fluvastatin extended-release and immediate-release formulations in the treatment of primary hypercholesterolemia: a randomized trial.
2001 Jan
Characterization of peptide substrates and viral enzyme that affect the cleavage site specificity of the human spumaretrovirus proteinase.
2001 Jan
Relationship between crevicular aspartate aminotransferase levels and periodontal disease progression.
2001 Jan
Dietary cancer risk from conditional cancerogens (tumor promoters) in produce of livestock fed on species of spurge (Euphorbiaceae). IV. Toxicologic and pathophysiologic observations in lactating goats and their suckling kids fed on the irritant herbs Euphorbia nubica and Euphorbia helioscopia: an etiologic model for investigations on the putative risk of cancer by consumption of food p.
2001 Jan
Exercise improved accumulation of visceral fat and simultaneously impaired endothelium-dependent relaxation in old rats.
2001 Jan
Use of intraosseous blood for repeated hematologic and biochemical analyses in healthy pigs.
2001 Jan
Oxygen free radical generation in healthy blood donors and cardiac patients: the protective effect of allopurinol.
2001 Jan
The effect of amino acid-modifying reagents on chloroplast protein import and the formation of early import intermediates.
2001 Jan
Effects of aflatoxin and carotenoids on growth performance and immune response in mule ducklings.
2001 Jan
Lactococcus lactis LM0230 contains a single aminotransferase involved in aspartate biosynthesis, which is essential for growth in milk.
2001 Jan
A comparison of the effect of nitroparacetamol and paracetamol on liver injury.
2001 Jan
Redistribution of neuroactive amino acids in hippocampus and striatum during hypoglycemia: a quantitative immunogold study.
2001 Jan
Excitatory amino acid concentrations in ventricular cerebrospinal fluid after severe traumatic brain injury in infants and children: the role of child abuse.
2001 Jan
Microdialysis study of amino acid neurotransmitters in the spinal dorsal horn of patients undergoing microsurgical dorsal root entry zone lesioning. Technical note.
2001 Jan
Pregnancy complicated by pre-eclampsia-eclampsia with HELLP syndrome.
2001 Jan
Studies on the effects of lactate transport inhibition, pyruvate, glucose and glutamine on amino acid, lactate and glucose release from the ischemic rat cerebral cortex.
2001 Jan
Possible linkage between glutamate transporter and mitogen-activated protein kinase cascade in cultured rat cortical astrocytes.
2001 Jan
Propylene glycol toxicosis in a llama.
2001 Jan 15
Strain is more important than electrostatic interaction in controlling the pKa of the catalytic group in aspartate aminotransferase.
2001 Jan 16
Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY x 3702 in vitro and in vivo.
2001 Jan 5
Substrate translocation kinetics of excitatory amino acid carrier 1 probed with laser-pulse photolysis of a new photolabile precursor of D-aspartic acid.
2001 Jan 9
The effect of repeated gavage doses of fumonisin B1 on the sphinganine and sphingosine levels in vervet monkeys.
2001 Jul
Association between serum concentrations of hexachlorobenzene and polychlorobiphenyls with thyroid hormone and liver enzymes in a sample of the general population.
2001 Mar
Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes.
2001 Mar 1
Site-directed mutations in the mitochondrially encoded subunits I and III of yeast cytochrome oxidase.
2001 Mar 1
Differential effects of endomorphin-1 and -2 on amphetamine sensitization: neurochemical and behavioral aspects.
2001 Mar 1
Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferi.
2001 Mar 30
Patents

Sample Use Guides

Aspartic acid is a nutrient component found in animal and vegetable sources. In clinical trials to alleviate opioid abstinence it was administered orally.
Route of Administration: Oral
Activation of recombinant NMDA receptors was measured using two-electrode voltage clamp. Current and voltage electrodes were made from thin-walled borosilicate glass using a PP-830 electrode puller and when filled with 3 M KCl, possessed resistances of between 0.5 and 1.5 MΩ. Oocytes were voltage-clamped at potentials of -40 mV. Aspartate was able to activate wild type NR1/NR2A NMDA receptors with EC50 of 18.4 uM.
Substance Class Chemical
Created
by admin
on Sat Dec 16 01:50:02 GMT 2023
Edited
by admin
on Sat Dec 16 01:50:02 GMT 2023
Record UNII
74X989P9A6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DIPOTASSIUM ASPARTATE
INCI  
INCI  
Official Name English
KALIUM L-ASPARTATE
WHO-DD  
Systematic Name English
L-ASPARTIC ACID, POTASSIUM SALT (1:2)
Common Name English
Kalium l-aspartate [WHO-DD]
Common Name English
L-ASPARTIC ACID, DIPOTASSIUM SALT
Common Name English
ASPARTIC ACID, DIPOTASSIUM SALT, L-
Common Name English
DIPOTASSIUM ASPARTATE [INCI]
Common Name English
DIPOTASSIUM ASPARTATE ANHYDROUS
Common Name English
ASPARTIC ACID, DIPOTASSIUM SALT
Common Name English
Code System Code Type Description
ECHA (EC/EINECS)
217-892-4
Created by admin on Sat Dec 16 01:50:02 GMT 2023 , Edited by admin on Sat Dec 16 01:50:02 GMT 2023
PRIMARY
EPA CompTox
DTXSID90941993
Created by admin on Sat Dec 16 01:50:02 GMT 2023 , Edited by admin on Sat Dec 16 01:50:02 GMT 2023
PRIMARY
DAILYMED
74X989P9A6
Created by admin on Sat Dec 16 01:50:02 GMT 2023 , Edited by admin on Sat Dec 16 01:50:02 GMT 2023
PRIMARY
PUBCHEM
6454950
Created by admin on Sat Dec 16 01:50:02 GMT 2023 , Edited by admin on Sat Dec 16 01:50:02 GMT 2023
PRIMARY
CAS
2001-89-0
Created by admin on Sat Dec 16 01:50:02 GMT 2023 , Edited by admin on Sat Dec 16 01:50:02 GMT 2023
PRIMARY
FDA UNII
74X989P9A6
Created by admin on Sat Dec 16 01:50:02 GMT 2023 , Edited by admin on Sat Dec 16 01:50:02 GMT 2023
PRIMARY
RXCUI
2397119
Created by admin on Sat Dec 16 01:50:02 GMT 2023 , Edited by admin on Sat Dec 16 01:50:02 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE